P1030: SPLEEN VOLUME REDUCTION PREDICTS SURVIVAL IN MYELOFIBROSIS PATIENTS ON PACRITINIB BUT NOT BEST AVAILABLE THERAPY: PERSIST-2 LANDMARK OVERALL SURVIVAL ANALYSIS

por Bewersdorf, Jan, Ajufo, Helen, Harrison, Claire, Palandri, Francesca, Mascarenhas, John, Palmer, Jeanne, Gerds, Aaron T., Kiladjian, Jean-Jacques, Derkach, Andrii, Roman-Torres, Karisse, Buckley, Sarah, Rampal, Raajit K
Publicado 2023